Effect of Dacarbazine Chemotherapy in Well-Differentiated Neuroendocrine Tumors

被引：0
作者：
Mueller, D. [1 ]
Rinke, A. [1 ]
Gress, T. [1 ]
机构：
[1] Univ Marburg, Dept Internal Med, Div Gastroenterol & Endocrinol, D-3550 Marburg, Germany
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine tumor; chemotherapy; dacarbazine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [21] The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond
    Sorbye, Halfdan
    Baudin, Eric
    Perren, Aurel
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) : 683 - +
  • [22] Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
    Prasad, Vishnu
    Sreelakshmi, Charakkulam Vijay
    Chandran, K. Ravi
    Agrawal, Shashank
    Pooleri, Ginil Kumar
    Sao, Amrita
    JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (02): : 8 - 12
  • [23] A well-differentiated neuroendocrine tumor of the left kidney
    Jiang, Hongyan
    Yang, Ling
    Luo, Ting
    Zhao, Yunfei
    ASIAN JOURNAL OF SURGERY, 2024, 47 (12) : 5414 - 5415
  • [24] Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors
    Mohamad Bassam Sonbol
    Thorvardur R. Halfdanarson
    Current Treatment Options in Oncology, 2019, 20
  • [25] Comparison of Methods for Proliferative Index Analysis for Grading Pancreatic Well-Differentiated Neuroendocrine Tumors
    Goodell, Pamela P.
    Krasinskas, Alyssa M.
    Davison, Jon M.
    Hartman, Douglas J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (04) : 576 - 582
  • [26] Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
    Jimenez-Fonseca, P.
    Carmona-Bayonas, A.
    Martin-Perez, E.
    Crespo, G.
    Serrano, R.
    Llanos, M.
    Villabona, C.
    Garcia-Carbonero, R.
    Aller, J.
    Capdevila, J.
    Grande, E.
    CANCER AND METASTASIS REVIEWS, 2015, 34 (03) : 381 - 400
  • [27] Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
    P. Jiménez-Fonseca
    A. Carmona-Bayonas
    E. Martín-Pérez
    G. Crespo
    R. Serrano
    M. Llanos
    C. Villabona
    R. García-Carbonero
    J. Aller
    J. Capdevila
    E. Grande
    Cancer and Metastasis Reviews, 2015, 34 : 381 - 400
  • [28] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Krug, Sebastian
    Kegel, Thomas
    Gress, Thomas M.
    Rinke, Anja
    Apostolidis, Leonidas
    Jann, Henning
    Koenig, Alexander
    Hoersch, Dieter
    Schrader, Joerg
    Ettrich, Thomas J.
    Richter, Michael
    Steighardt, Joerg
    Michl, Patrick
    BMC CANCER, 2021, 21 (01)
  • [29] Plasma Neurokinin A Levels Predict Survival in Well-Differentiated Neuroendocrine Tumors of the Small Bowel
    Woltering, Eugene A.
    Voros, Brianne A.
    Thiagarajan, Ramcharan
    Beyer, David T.
    Ramirez, Robert A.
    Wang, Yi-Zarn
    Mamikunian, Gregg
    Boudreaux, J. Philip
    PANCREAS, 2018, 47 (07) : 843 - 848
  • [30] Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
    Pellat, Anna
    Cottereau, Anne Segolene
    Palmieri, Lola-Jade
    Soyer, Philippe
    Marchese, Ugo
    Brezault, Catherine
    Coriat, Romain
    CANCERS, 2021, 13 (10)
12345